Table 4.
Fibrosis stage | Model | Cutoff value | Sen | Spec | PPV | NPV | AUROC |
F0-F1 vs F2-F4 | Model A | 0.8032 | 0.871 | 0.839 | 0.951 | 0.642 | 0.890 |
GlycoFibroTest | -0.4404 | 0.280 | 0.903 | 0.913 | 0.257 | 0.538 | |
GlycoCirrhoTest | -0.2946 | 0.778 | 0.452 | 0.837 | 0.359 | 0.644 | |
APRI | 0.4871 | 0.626 | 0.839 | 0.933 | 0.385 | 0.790 | |
FIB-4 | 0.4720 | 0.401 | 0.855 | 0.908 | 0.285 | 0.599 | |
S index | 0.0543 | 0.742 | 0.596 | 0.871 | 0.386 | 0.701 | |
Model A + ALT + PLT | 0.7779 | 0.923 | 0.806 | 0.945 | 0.746 | 0.912 | |
F0-F2 vs F3-F4 | Model B | 0.3418 | 0.986 | 0.514 | 0.662 | 0.974 | 0.752 |
GlycoFibroTest | -0.2295 | 0.128 | 1.000 | 1.000 | 0.543 | 0.524 | |
GlycoCirrhoTest | 0.0033 | 0.270 | 0.911 | 0.745 | 0.564 | 0.618 | |
APRI | 0.3964 | 0.819 | 0.562 | 0.638 | 0.766 | 0.740 | |
FIB-4 | 0.3930 | 0.609 | 0.726 | 0.677 | 0.663 | 0.699 | |
S index | 0.0890 | 0.664 | 0.711 | 0.690 | 0.686 | 0.738 | |
Model B + ALT + PLT | 0.4404 | 0.855 | 0.685 | 0.720 | 0.833 | 0.829 | |
F0-F3 vs F4 | Model C | 0.2258 | 0.808 | 0.598 | 0.407 | 0.901 | 0.747 |
GlycoFibroTest | -0.3200 | 0.274 | 0.939 | 0.606 | 0.791 | 0.571 | |
GlycoCirrhoTest | -0.0287 | 0.356 | 0.827 | 0.413 | 0.790 | 0.607 | |
APRI | 0.4206 | 0.859 | 0.488 | 0.359 | 0.912 | 0.666 | |
FIB-4 | 0.3762 | 0.831 | 0.657 | 0.447 | 0.921 | 0.795 | |
S index | 0.0817 | 0.765 | 0.571 | 0.380 | 0.876 | 0.717 | |
Model C + ALT + PLT | 0.3010 | 0.789 | 0.845 | 0.629 | 0.923 | 0.885 |
F1 APRI = [AST (IU/L) / 40] × 100/PLT (109/L). F2 FIB-4 = [age (yr) × AST (IU/L)] / [PLT (109 /L) × ALT1/2 (IU/L)]. F3 S index = 1000 × GGT (IU/L) / [PLT (109/L) × ALB2 (g/L)]. Sen: Sensitivity; Spec: Specificity; PPV: Positive predictive value; NPV: Negative predictive value; ALT: Alanine aminotransferase; GGT: γ-glutamyl-transpeptidase; PLT: Platelet; AUROC: Area under receiver operating characteristic curves.